The company has received final approval from the Department of Pharmaceuticals, Government of India, for foreign investment under applicable regulations
Metropolis Clinical Pathology will acquire and operate all laboratories and collection centers of Scientific Pathology in Agra and neighbouring towns through a slump sale transaction
Acquisition expands high-value medical platform
Aims to become India’s leading cancer testing company
Potential to optimize and build on the synergies in commercial operations, distribution, manufacturing, supply chain etc.
Acquisition in line with Mankind’s stated objective to expand its presence in high entry barrier complex portfolios and high potential OTX brands
Dr. Roopal Thakkar joined Abbott/AbbVie in 2003 as part of the Physician Development Program
Acquisition will advance Merck’s integrated offering for viral vector manufacturing
Subscribe To Our Newsletter & Stay Updated
